Regulator investigating pharmacists following report on gender prescribing at GP practice Exclusive: The General Pharmaceutical Council said it opened its investigation after a report revealed how “potential harm” had been caused to 78 children and young people seeking support for gender dysphoria or incongruence.…
Branded medicines levy cut under statutory scheme The Department of Health and Social Care said that the new 16.5% levy, a fall from the previous year’s 24.3%, will take effect from 1 July 2026.…
Health news round-up: elecoglipron, antibiotic resistant E. coli and low blood pressure risk in frailty The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
The impact of pharmacist-led medication intervention on patient perception and satisfaction following new acute coronary syndrome diagnosis prior to hospital discharge Cardiovascular disease is a major cause of morbidity and mortality, with acute coronary syndrome (ACS) remaining the leading cause of hospital admissions in the UK1,2. Strict adherence to the national guideline directed pharmacotherapy for secondary prevention of ACS is vital to improve patien…
MHRA approves semaglutide oral tablets for weight loss The Medicines and Healthcare products Regulatory Agency advises that patients must start at the lowest 1.5mg daily dose of oral semaglutide tablets, which can be further increased to 4mg, 9mg and 25mg doses.…
The Critical Medicines Act: can the UK manage supply problems with the EU’s ‘safety belt’? Pharmacy leaders are hopeful that the Critical Medicines Act will help to alleviate medicines shortages in the UK, which have been rumbling on for several years.…
Drugs used for airway clearance in critically ill patients found to cause harm Researchers found that carbocisteine increased the risk of gastrointestinal bleeding, while hypertonic saline was associated with an increased risk of nebulisation-related harms in critically ill patients on mechanical ventilators.…
Kathie Cashell: ‘You can’t protect the public without an empowered profession’ As fitness-to-practise complaints to the General Pharmaceutical Council hit record highs, we spoke to new chief executive Kathie Cashell about her priorities for the organisation and the improvements she wants to deliver.…
Regulator vows to prioritise racism review recommendations General Pharmaceutical Council chief executive, Kathie Cashell, said “urgent, demonstrable and visible action is needed by all leaders”, following the publication of the Mann review.…
Early-onset type 2 diabetes mellitus: identification and management An overview of early-onset type 2 diabetes mellitus, including its pathophysiology, diagnosis and management, as well as approaches for younger adults.…
